Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

16.03 +1.17 (+7.87%)
Streaming Delayed Price Updated: 2:03 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2 3 4 Next >
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Resignation of Board Member
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
From DBV Technologies S.A.
Via GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Participate in Upcoming EAACI Congress 2025
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
From DBV Technologies S.A.
Via GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
From DBV Technologies S.A.
Via GlobeNewswire
Combined General Meeting of June 11, 2025
From DBV Technologies S.A.
Via GlobeNewswire
Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Reports First Quarter 2025 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
From DBV Technologies S.A.
Via GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
From DBV Technologies S.A.
Via GlobeNewswire
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
From DBV Technologies S.A.
Via GlobeNewswire
Information regarding the total number of voting rights and  total number of shares of the Company as of November 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Reports Third Quarter 2024 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Via AB Newswire
Topics Intellectual Property
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
From DBV Technologies S.A.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.